Dry eye Disease During COVID-19 : Need for Investment Into Research to Develop Solutions?

Coronavirus disease 2019 (COVID-19): What we need to know (In Press)

Medical strategies for Disease Covid-19

Following the outbreak of Covid-19, many related studies were published rapidly around the world. In this study, we examined published or in-publication studies over the strategies to deal with Covid-19. To this end, 16 published scientific papers were investigated using content analysis and meta-analysis. As a result, 16 medical strategies and 3 macro-management strategies were extracted. Fina...

Nutrition during COVID-19

In December 2019, a new strain of the corona virus, as a subset of coronaviruses was identified for the first time in Wuhan, China. Symptoms included fever, cough, and muscle aches that are very similar to the seasonal flu.

The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research

Purpose Biomarkers with minimally invasive and reproducible objective metrics provide the key to future paradigm shifts in understanding of the underlying causes of dry eye disease (DED) and approaches to treatment of DED. We review biomarkers and their validity in providing objective metrics for DED clinical research and patient care. Methods The English-language literature in PubMed primari...

Dry Eye Disease

Dry eye disease (DED) is a clinically significant multifactorial disorder of the ocular surface and tear film as it results in ocular discomfort and visual impairment and predisposes the cornea to infections. It is important for the quality of life and tends to be a chronic disease. It is also common, as the prevalence is estimated between 5 % to 30 % and this increases with age. Therefore, it ...